The Chemistry Department would like to congratulate Craig Crews, Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry and of Pharmacology, on receiving the American Association for Cancer Research Award for Outstanding Achievement in Chemistry in Cancer Research. This award is presented for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, the prevention of cancer, or the treatment of patients with cancer. Craig Crews is honored for his seminal work toward developing the epoxyketone class of proteasome inhibitors, including Carfilzomib/KyprolisTM. Also recognized is Dr. Crews’ ability to take an anti-cancer agent developed from a basic research project in an academic laboratory through to an FDA-approved therapeutic. His unwavering commitment to chemical biology truly embodies a “bench-to-bedside” approach that has a direct impact on patients.
Click here for the AACR news article regarding Dr. Crews’ achievement.